Oleylphosphocholine

N/A

Report date: 2023/12/07 14:20:31
NME

Base Information

Drug NameOleylphosphocholine
Drug Alias NameOIPCD-121
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell division inhibitors
TargetsNot applicable
Therapy Area/IndicationsChagas DiseaseLeishmaniasis, MucocutaneousLeishmaniasis +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMax Planck Innovation
China Registration ClassN/A

Develop Information

Active CompaniesOblita Therapeutics BVBA
Active IndicationsChagas DiseaseLeishmaniasis, MucocutaneousLeishmaniasis +[4
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A